S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q3 2022

RA Capital Management

Period: Q3 2022 Β· Filed: 2022-11-14
View on SEC EDGAR β†—
AUM
$4.69B
Total portfolio value
Positions
81
Reported securities
Top Holding
ASND
16.7% $781.5M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S$781.5M16.67%$103.26$274.50+165.8%
16.7%
BIIBBIOGEN INC$250.3M5.34%$267.00$216.12-19.1%
5.3%
CTKBCYTEK BIOSCIENCES INC$197.0M4.20%$14.72$4.59-68.8%
4.2%
FMTXFORMA THERAPEUTICS HLDGS INC$179.8M3.84%β€”β€”
3.8%
DAWNDAY ONE BIOPHARMACEUTICALS I$141.0M3.01%β€”β€”
3.0%
AVTEAEROVATE THERAPEUTICS INC$137.0M2.92%β€”β€”
2.9%
RYTMRHYTHM PHARMACEUTICALS INC$134.0M2.86%$24.50$114.17+366.0%
2.9%
TVTXTRAVERE THERAPEUTICS INC$121.3M2.59%$24.64$56.92+131.0%
2.6%
BLUBELLUS HEALTH INC NEW$120.2M2.56%β€”β€”
2.6%
JANXJANUX THERAPEUTICS INC$117.4M2.50%$13.54$15.54+14.8%
2.5%
PCVXVAXCYTE INC$110.0M2.35%$24.00$58.39+143.3%
2.4%
DICEDICE THERAPEUTICS INC$105.6M2.25%β€”β€”
2.3%
IMGNIMMUNOGEN INC$103.9M2.22%β€”β€”
2.2%
NKTXNKARTA INC$102.7M2.19%$13.16$3.22-75.5%
2.2%
ABOSACUMEN PHARMACEUTICALS INC$98.0M2.09%$10.03$2.74-72.7%
2.1%
LEGNLEGEND BIOTECH CORP$95.4M2.04%$40.80$29.91-26.7%
2.0%
ITOSITEOS THERAPEUTICS INC$84.2M1.80%β€”β€”
1.8%
RLMDRELMADA THERAPEUTICS INC$74.0M1.58%$37.02$6.28-83.0%
1.6%
PEPGPEPGEN INC$73.8M1.58%$9.08$1.76-80.6%
1.6%
GERNGERON CORP$70.5M1.50%$2.34$1.36-41.9%
1.5%
ACRSACLARIS THERAPEUTICS INC$69.2M1.48%$15.74$5.56-64.7%
1.5%
THRDTHIRD HARMONIC BIO INC$65.9M1.41%β€”β€”
1.4%
ANTXAN2 THERAPEUTICS INC$65.6M1.40%$17.38$4.42-74.6%
1.4%
TYRATYRA BIOSCIENCES INC$63.6M1.36%$8.79$30.62+248.3%
1.4%
WVEWAVE LIFE SCIENCES LTD$62.1M1.32%$3.61$6.26+73.4%
1.3%
VRNAVERONA PHARMA PLC$61.8M1.32%β€”β€”
1.3%
COGTCOGENT COMMUNICATIONS HLDGS$59.9M1.28%$14.92$38.69+159.3%
1.3%
NSTGQNANOSTRING TECHNOLOGIES$58.8M1.25%β€”β€”
1.3%
CLDXCELLDEX THERAPEUTICS INC NEW$58.3M1.24%$28.11$38.37+36.5%
1.2%
GHRSGH RESEARCH PLC$56.9M1.21%$11.62$27.01+132.4%
1.2%

Quarter-on-Quarter Activity

Q3 2022 vs. Q2 2022

New Positions (8)

TickerIssuerNotionalSince Filing
LEGNLEGEND BIOTECH CORP$95.4M-26.7%
THRDTHIRD HARMONIC BIO INC$65.9M
COGTCOGENT COMMUNICATIONS HLDGS$59.9M+159.3%
FULCFULCRUM THERAPEUTICS INC$56.6M
AKROAKERO THERAPEUTICS INC$32.6M
ALPNALPINE IMMUNE SCIENCES INC$31.4M
ACETADICET BIO INC$29.3M
VRDNVIRIDIAN THERAPEUTICS INC$18.1M

Exited Positions (8)

TickerIssuerNotional
VERUXXXXVERU INC$89.3M
PNTPOINT BIOPHARMA GLOBAL INC$61.3M
NTRANATERA INC$46.4M
DYNDYNE THERAPEUTICS INC$19.3M
GHGUARDANT HEALTH INC$19.2M
OTICOTONOMY INC$11.7M
LIANYLIANBIO$10.0M
IPSCCENTURY THERAPEUTICS INC$6.4M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
WHWKAADI BIOSCIENCE INC$3.6M+54.1%
RLAYRELAY THERAPEUTICS INC$6.9M+30.7%
BIIBBIOGEN INC$102.1M+29.0%-19.1%
NSTGQNANOSTRING TECHNOLOGIES$13.3M+28.4%
DSGNDESIGN THERAPEUTICS INC$15.8M+26.8%
VRNAVERONA PHARMA PLC$40.5M+18.6%
BOLTBOLT BIOTHERAPEUTICS INC$-0.1M+18.5%
RYTMRHYTHM PHARMACEUTICALS INC$113.8M+12.3%+366.0%

Trimmed (7)

TickerIssuerNotionalShares Ξ”
CNCECONCERT PHARMACEUTICALS INC$-6.6M-67.1%
TNYATENAYA THERAPEUTICS INC$-15.3M-54.9%
SYBXSYNLOGIC INC$-2.3M-20.7%
PYXSPYXIS ONCOLOGY INC$-0.8M-19.8%
ENTXENTERA BIO LTD$-1.0M-11.5%
SNSESENSEI BIOTHERAPEUTICS$-0.6M-5.5%
HSAQHEALTH SCIENCES ACQ CORP 2$-0.2M-2.4%
← Back to Hedge Funds